NCT07298161 · Efforia, Inc
Evaluating SleepWhale Drops for Rest & Resilience
What this study is about
30-day study evaluating SleepWhale Natural Sleep Drops (Extra Strength)-formulated to support deeper sleep and better days.
View original scientific description
30-day study evaluating SleepWhale Natural Sleep Drops (Extra Strength)-formulated to support deeper sleep and better days.
Interventions
DIETARY_SUPPLEMENT
SleepWhale Natural Sleep Drops
Broad spectrum hemp extract: 25 mg Broad spectrum hemp extract (CBN): 1.5 mg Proprietary blend of Suntheanine (L-Theanine), GadoMag (Magnesium( Sibelius (Camomile) and M2 (Lion's Mane)
Primary outcome measures
PROMIS Sleep Disturbance Scale
Time frame: Change from baseline (Day 1-3) in PROMIS Sleep Disturbance Scale at 4 weeks (Day 28-32)
The PROMIS Sleep Disturbance Scale is a validated and widely used assessment tool developed as part of the Patient-Reported Outcomes Measurement Information System (PROMIS) initiative. It is designed to measure the severity of sleep disturbances and disruptions experienced by individuals. This scale includes a range of questions that assess the frequency and impact of various sleep-related issues, such as difficulty falling asleep, nighttime awakenings, and restless sleep. Healthcare professionals and researchers rely on this scale to better understand and quantify sleep problems in patients, enabling them to tailor interventions and treatment strategies to address sleep-related concerns effectively. Unabbreviated Scale Title Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance Scale Score Range Short Form (e.g., 8a): 8-40 Score Interpretation Higher scores = worse sleep disturbance Lower scores indicate better sleep quality
Daytime Sleepiness Perception Scale (DSPS-4)
Time frame: Change from baseline (Day 1-3) in DSPS-4 at 4 weeks (Day 28-32)
This survey is designed to measure your perception of daytime sleepiness. Please read each statement carefully and circle the response that best applies to your experience. Score Range Each item typically scored 0-4 or 1-5 Total score range (most common): 0-16 Score Interpretation Higher scores = greater perceived daytime sleepiness Lower scores indicate better daytime alertness
Fatigue Perception and Impact Survey
Time frame: Change from baseline (Day 1-3) in FPIS at 4 weeks (Day 28-32)
The Fatigue Perception and Impact Survey (FPIS) is a specialized questionnaire developed to evaluate the presence, severity, and impact of fatigue on an individual's life. Comprising a series of questions, the survey aims to capture both the subjective experience of fatigue and its consequences across various domains, such as physical, emotional, and social aspects. This tool is commonly used in clinical settings to assess fatigue in patients with various medical conditions, including chronic illnesses and cancer, helping healthcare professionals better understand and address the debilitating effects of fatigue on patients' quality of life. Researchers also employ the FPIS to gather valuable data on fatigue patterns. Score Range 0-4 or 1-5 Likert items Total score range 0-50 Score Interpretation Higher score= worse fatigue and greater functional impact Lower score= less perceived fatigue
Resilience Assessment Scale
Time frame: Change from baseline (Day 1-3) in Resilience Assessment Scale at 4 weeks (Day 28-32)
This survey aims to evaluate your level of resilience in different situations. Score Range 0-100 (scaled score) Score Interpretation Higher scores = greater resilience (better outcome) Lower scores indicate reduced psychological resilience
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Can read and understand English.
- US resident.
- Willing and able to follow the requirements of the protocol.
Exclusion criteria
- Individuals with Allergies to supplement ingredients
- Individuals on sleep Medication
- Individuals with Gastrointestinal Issues
- Individuals with Skin Conditions
- Individuals Prone to Headaches
- Individuals with Mental Health Conditions
- Pregnant or Breastfeeding Individuals
- Athletes and Competitive Participants
- Individuals with Dependency Issues
- Individuals with Dizziness or Fatigue Issues
Where
- New York, New York
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Dec 23, 2025 · Source of record for eligibility and locations